HealthcareNasdaqmid
Institutional-grade research for retail investors
SEC EDGAR: CIK 914156UFPT stock profile & AI dashboard →

13F Pro Quality Score

63.1/100

Rank #661 of 2,962 stocksTOP 25%

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

82.9/100

Profitability

66.9/100

Balance Sheet

87.3/100

Earnings Quality

61.5/100

Free Cash Flow

54.8/100

Institutional Flow

25.6/100

Revenue Scale

41.0/100

Dilution Risk

46.9/100
Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

UFPT Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for UFP TECHNOLOGIES INC (UFPT), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores UFPT at 63.1/100 on a 32-signal composite quality model, placing it at rank #661 of 2,962 stocks — the top 25% of the AI-ranked universe. UFPT scores in the top quartile across balance sheet strength (87.3), revenue growth (82.9). Areas of concern include institutional flow (25.6), which score below median versus the broader universe. Shareholder dilution risk is elevated at 46.9/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), UFP TECHNOLOGIES INC reports quarterly revenue of $174.0M, net income of $20.9M, an operating margin of 16.2%. Top institutional holders of UFPT by reported 13-F value include BlackRock, CONGRESS ASSET MANAGEMENT, WASATCH ADVISORS, based on the most recent SEC filings. UFPT trades on the Nasdaq exchange and files with the SEC under CIK 914156. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate UFPT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for UFP TECHNOLOGIES INC directly from SEC EDGAR. UFP TECHNOLOGIES INC's 13F Pro composite quality score has ranged between 50 and 68 since 2025, currently 63.1 — a stable long-term trajectory across 52 quarterly and live scoring snapshots.

Fun facts about UFP TECHNOLOGIES INC

Quirks, history, and lore behind UFPT — the kind of stuff that makes a stock memorable.

  • 1
    The Basics
    U.S. small-cap manufacturer · listed on Nasdaq · headquartered in Massachusetts · serves the healthcare and medical markets.
  • 2
    The Numbers
    Annual revenue in the low hundreds of millions of dollars — not a giant, but a specialist that punches above its weight in high-value custom components.
  • 3
    The History
    Traces its roots back to the 1940s in New England, growing over decades from a regional packaging operation into a focused advanced materials converter.
  • 4
    The Secret
    Its real skill is cutting, forming, and laminating foam, fiber, and film into precise shapes — think sterile packaging and single-use surgical components nobody else wants to bother making.
  • 5
    The Lore
    The company leaned hard into medical device packaging and wound-care components, making it quietly essential to hospital supply chains across North America.
  • 6
    The Giveaway
    Its ticker is four letters ending in PT, its home is Newburyport, MA, and it literally has the words "Technologies" and "Fabricating Packaging" baked into its DNA.
▶ Think you know your stocks? Play the Daily Ticker

What's Driving UFPT's Business? Latest 10-Q Breakdown

AI-extracted from UFP TECHNOLOGIES INC's 10-Q filed 2026-08-06 — Q2 FY2026 (six months ended June 30, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.

UFP Technologies grew six-month revenue 9.6% to $328.2M with organic growth of 6.8%, driven by Medical market strength, while gross margin improved to 29.0% despite SG&A cost inflation.

Biggest Revenue Drivers

Products$324.3M+10.1% YoY

AI-extracted and verified against SEC EDGAR filing text. Not investment advice.

Revenue

Q2 2026

$174.0M

Net Income

Q2 2026

$20.9M

Operating Margin

Q2 2026

16.2%

ROIC

Q2 2026

19.0%

D/E Ratio

Q2 2026

0.28

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

+19.5% YoY
$602.8MFY 2025
FY22 $353.8MFY23 $400.1MFY24 $504.4MFY25 $602.8M

Net Income

+15.8% YoY
$68.3MFY 2025
FY22 $41.8MFY23 $44.9MFY24 $59.0MFY25 $68.3M

Operating Income

+14.1% YoY
$92.3MFY 2025
FY22 $55.4MFY23 $57.7MFY24 $80.9MFY25 $92.3M

EPS (Diluted)

+15.4% YoY
$8.75FY 2025
FY22 $5.45FY23 $5.83FY24 $7.58FY25 $8.75

Total Assets

+4.1% YoY
$655.1MFY 2025
FY22 $378.2MFY23 $404.1MFY24 $629.0MFY25 $655.1M

Total Debt

-26.7% YoY
$148.0MFY 2025
FY22 $59.0MFY23 $36.0MFY24 $201.9MFY25 $148.0M

Op. Cash Flow

+38.0% YoY
$91.9MFY 2025
FY22 $17.7MFY23 $41.3MFY24 $66.6MFY25 $91.9M

Free Cash Flow

FY 2025
FY22 $4.0MFY23 $30.8MFY24 $56.9MFY25

Get alerted when UFPT's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for UFP TECHNOLOGIES INC including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of UFPT

Companies Similar to UFPT

Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.

LMAT

LEMAITRE VASCULAR INC

66
AI score
Similar quality profile · 24 shared holders
IRMD

IRADIMED CORP

63
AI score
Similar quality profile · 16 shared holders
ENSG

ENSIGN GROUP, INC

67
AI score
Similar quality profile · 15 shared holders
TECH

BIO-TECHNE Corp

59
AI score
Similar quality profile · 7 shared holders
VCEL

Vericel Corp

62
AI score
Similar quality profile · 17 shared holders
MD

Pediatrix Medical Group, Inc.

55
AI score
Similar quality profile · 10 shared holders
BFAM

BRIGHT HORIZONS FAMILY SOLUTIONS INC.

61
AI score
Similar quality profile · 10 shared holders
PBH

Prestige Consumer Healthcare Inc.

54
AI score
Similar quality profile · 8 shared holders

Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.

Put UFPT on your watchlist

Track score changes the day UFP TECHNOLOGIES INC files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is UFPT a good stock to buy?

13F Pro's AI-powered analysis of UFP TECHNOLOGIES INC (UFPT) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for UFPT are available on the UFPT stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. UFPT is classified as a mid company.

Which hedge funds own UFPT?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling UFPT. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of UFP TECHNOLOGIES INC's investment landscape.